-

FoodScience, LLC Announces Acquisition of Natural Dog Company, Expanding Leadership in Pet Wellness

WILLISTON, Vt.--(BUSINESS WIRE)--FoodScience, LLC, a leading provider of premium health and wellness solutions for pets and people, today announced the acquisition of Natural Dog Company, a brand known for its high-quality dog care products. Founded in 2006 and based in North Carolina, Natural Dog Company has earned loyal customers through its dedication to effective solutions.

This marks the first acquisition for FoodScience since becoming a portfolio company of Morgan Stanley Capital Partners (MSCP) in November 2024.

“We believe Natural Dog Company is a strong strategic fit for FoodScience,” said James Stewart, Managing Director and Co-Head of Consumer Investing at MSCP. “This acquisition reflects our commitment to investing behind category-defining brands with loyal followings, differentiated products, and strong growth potential. We believe the combination of the Natural Dog brand and FoodScience’s operational excellence will accelerate growth and drive long-term value creation.”

Sharon Rossi, Chief Executive Officer of FoodScience, commented: “We are delighted to welcome Natural Dog Company to FoodScience. This acquisition represents an important step in our growth journey and expands our presence in pet wellness and supplements. Natural Dog brings a highly respected brand that aligns with our values and long-standing commitment to quality and innovation. Together, we’ll continue delivering trusted solutions for pets and the people who care for them.”

Bill D’Alessandro, CEO of Natural Dog Company, added: “We weren’t looking for just any buyer—we were looking for the right partner. FoodScience shares our obsession with product quality, our passion for pet wellness, and our belief in doing things the right way. They’ve built trust with customers for over 50 years and have deep expertise in areas that will help Natural Dog grow even stronger. I’m incredibly excited for what we are going to build together—and for all the good we’ll continue to do for dogs and their humans.”

Terms of the transaction were not disclosed.

About FoodScience, LLC
Based in Williston, Vermont, FoodScience, LLC is a leading developer, manufacturer, and marketer of health and wellness supplements for pets and humans. With more than 50 years of experience, the company is known for its product innovation, rigorous quality standards, and trusted brands including VetriScience®, Pet Naturals®, and DaVinci Labs®. www.foodsciencecorp.com

About Natural Dog Company
Founded in 2006, Natural Dog Company offers a portfolio of high-quality products designed to keep dogs healthy, happy, and active—from skin and coat solutions to supplements and grooming care. With a devoted customer base and a strong digital presence, the brand is known for its integrity, transparency, and love for dogs. www.naturaldog.com

About Morgan Stanley Capital Partners

Morgan Stanley Capital Partners, part of Morgan Stanley Investment Management, is a leading middle-market private equity platform established in 1986 that focuses on privately negotiated equity and equity-related investments primarily in North America. Morgan Stanley Capital Partners seeks to create value in portfolio companies primarily in a series of subsectors in the business and consumer, healthcare, and industrial services markets with an emphasis on driving significant organic and acquisition growth through an operationally focused approach. For further information about Morgan Stanley Capital Partners, please visit www.morganstanley.com/im/capitalpartners.

Contacts

Media:

Morgan Stanley: Alyson Barnes
alyson.barnes@morganstanley.com

FoodScience


Release Versions

Contacts

Media:

Morgan Stanley: Alyson Barnes
alyson.barnes@morganstanley.com

More News From FoodScience

Morgan Stanley Investment Management Announces Liquidation of Calvert US Large-Cap Diversity, Equity and Inclusion Index ETF (CDEI)

NEW YORK--(BUSINESS WIRE)--Morgan Stanley Investment Management today announced the upcoming liquidation of Calvert US Large-Cap Diversity, Equity and Inclusion Index ETF (CDEI) (the Fund), a series of Morgan Stanley ETF Trust (the Trust). The Board of the Trust approved a Plan of Liquidation with respect to the Fund. Pursuant to the Plan of Liquidation, the assets of the Fund will be liquidated, known or reasonably ascertainable liabilities of the Fund will be satisfied or provided for, the re...

Morgan Stanley Investment Management's 1GT Leads €49 Million Series E Funding for Amber Electric

LONDON--(BUSINESS WIRE)--Morgan Stanley Investment Management (MSIM) announced today that the 1GT private climate equity strategy (1GT) led a €49 million Series E financing round for Amber Electric (Amber or the Company), an energy flexibility platform that enables customers to optimize how they store and use energy at home. This funding will support the Company’s continued growth and expansion in Europe. It follows the recent partnership with E.ON, one of the UK’s largest energy suppliers, whi...

Certain Morgan Stanley Closed-End Funds Declare Quarterly Dividends

NEW YORK--(BUSINESS WIRE)--Each of the Morgan Stanley closed-end funds listed below (the “Funds”) today declared the following dividends. RECORD DATE PAYABLE DATE 9/30/26 10/15/26   Name of Closed-End Fund NYSE Ticker Net Investment Income Per Share Morgan Stanley Emerging Markets Debt Fund, Inc. MSD $0.145 Morgan Stanley Emerging Markets Domestic Debt Fund, Inc. EDD $0.21 For more information call: 1-800-231-2608. The amount of net investment income to be paid by the Funds is determined in acc...
Back to Newsroom